Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers

Author(s):  Zur Eyal

Issue:  Nov/Dec 2011 - Volume 15, Number 6
View All Articles in Issue

Page(s):  458-463

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 1
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 2
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 3
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 4
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 5
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 6

Download in electronic PDF format for $65

Abstract:  Part 2 of a 2-part article about infantile hemangiomas, the most common benign tumors of infancy, was published previously in the International Journal of Pharmaceutical Compounding. Part 1 provided a comprehensive discussion about infantile hemangiomas, the current accumulative knowledge in the treatment of this pathology, and the use of oral propranolol in the treatment of infantile hemangiomas. This article continues that discussion but focuses on the topical treatment of this pathology.

Related Keywords: Eyal Zur, RPh, MBA, formulations, infantile hemangioma, infants, steroids, corticosteroids, immune response modifiers, beta blockers, topical preparations, literature review, iontophoresis, propranolol hydrochloride, skin permeability, percutaneous absorption

Related Categories: CANCER AND AIDS, DERMATOLOGY, FORMULATIONS, PEDIATRICS, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride
Zur Eyal
Sep/Oct 2011
Pg. 358-366

Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C
, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Jul/Aug 2014
Pg. 332-340

Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Zur Eyal
Nov/Dec 2012
Pg. 462-469

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
Jul/Aug 2017
Pg. 282-289

Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Zur Eyal
Sep/Oct 2012
Pg. 386-393

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit
, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Mar/Apr 2020
Pg. 168-175

In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie
, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2014
Pg. 512-515

In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Kohan Hamed Gilzad
, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2021
Pg. 146-155